AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $14,198,000 | -81.5% | 5,656,462 | 0.0% | 0.45% | -81.9% |
Q2 2020 | $76,815,000 | +79.2% | 5,656,462 | 0.0% | 2.48% | +47.2% |
Q1 2020 | $42,876,000 | +19.9% | 5,656,462 | 0.0% | 1.69% | +51.8% |
Q4 2019 | $35,749,000 | +61.2% | 5,656,462 | 0.0% | 1.11% | +78.9% |
Q3 2019 | $22,173,000 | -19.0% | 5,656,462 | 0.0% | 0.62% | -16.5% |
Q2 2019 | $27,377,000 | -40.9% | 5,656,462 | 0.0% | 0.74% | -42.8% |
Q1 2019 | $46,326,000 | +48.1% | 5,656,462 | 0.0% | 1.30% | +0.6% |
Q4 2018 | $31,280,000 | +216.5% | 5,656,462 | +405.4% | 1.29% | +395.4% |
Q3 2018 | $9,883,000 | – | 1,119,286 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |